Financing Brings Total Raised to $31.5 Million in Last 45 Days SKOKIE, Ill.–(BUSINESS WIRE)–Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing three-dimensional Spherical Nucleic Acid (SNA™) constructs, today announced the closing of approximately $11.2 million in subsequent financing led by Luye Pharma Group and others including Eager Info Investments LTD, Knoll Capital […]
To access this post, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users.